Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.55% Nasdaq Up0.29%

Infinity Pharmaceuticals, Inc. (INFI)

-NasdaqGS
9.79 Down 0.03(0.31%) Apr 15, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development26,592  26,857  26,080  20,231  
Selling General and Administrative6,492  7,319  6,675  7,430  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (33,084) (34,176) (32,755) (27,661)
Income from Continuing Operations
Total Other Income/Expenses Net159  238  164  335  
Earnings Before Interest And Taxes(32,925)(33,938)(32,591)(27,326)
Interest Expense -   -   -   -  
Income Before Tax(32,925)(33,938)(32,591)(27,326)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(32,925)(33,938)(32,591)(27,326)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (32,925) (33,938) (32,591) (27,326)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (32,925) (33,938) (32,591) (27,326)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.